Category:Stubs
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This category is for articles (or categories) which only contain a minimum of information. Please help to flesh them out (and then remove the "Stub" template tag once this is achieved).
Articles by date[edit | edit source]
List of "Stub" pages ordered by the date they were marked as "Stubs". |
---|
|
Subcategories
This category has the following 18 subcategories, out of 18 total.
S
- Stub pages last edited in 2015 (empty)
- Stub pages last edited in 2016 (17 P)
- Stub pages last edited in 2018 (16 P)
- Stub pages last edited in 2019 (43 P)
- Stub pages last edited in 2020 (20 P)
- Stub pages last edited in 2021 (90 P)
- Stub pages last edited in 2022 (285 P)
- Stub pages last edited in 2023 (619 P)
Pages in category "Stubs"
The following 200 pages are in this category, out of 1,106 total.
(previous page) (next page)M
- MitoQ
- Modafinil
- Mold illness
- Molybdenum
- Monocyte
- Montserrat Núñez
- Morphine
- MTHFR
- MTHFR and other methylation mutations
- MTHFR.net
- Multi-tasking problems
- Multiple virus hypothesis
- Multisystemic dyshomeostasis
- Muscle biopsy
- Muscular problems
- Mushroom extracts
- Mushrooms
- Myelin
- Myelin basic protein
- Myoclonus
- Myofascial pain syndrome
- Myopathy
- Ménière's disease
N
- Nabumetone
- Naghmeh Nikkheslat
- Narcolepsy
- NASA 10-minute lean test
- Nasal microbiome
- Natalie Lambert
- Natalie Moll
- National ME/FM Action Network
- Natural killer cell function test
- Nereida Littrell
- Nerve block
- Neuralgia
- Neuroendocrine symptoms
- Neuroendocrine system
- Neuroimmune model
- Neuron
- Neuronal PAS domain protein 2
- Neuroplasticity
- New Zealand
- Nexavir
- NHS Scotland
- Nicky Morgan
- Nicola Clague-Baker
- Nicola Mills
- Nicotinamide adenine dinucleotide
- Nigella sativa
- Night sweat
- Nilay Hepgul
- Nimodipine
- Nitric oxide
- Nitrogen hypothesis
- Nizatidine
- Nocturia
- Nod-like receptor protein 3
- Non-benzodiazepine hypnotic
- Non-invasive electrical vestibular stimulation
- Nonsteroidal anti-inflammatory drug
- Norepinephrine
- Norman Lamb
- Nortriptyline
- Nova Southeastern University
- Nrf2
- NT Factor
- NTRK
- Nuclear receptor subfamily 3 group C member 1
- Nuedexta
- Nutrition
O
- Obsessive-compulsive disorder
- Occipital cortex
- Ocrelizumab
- Odor sensitivities
- Olfactory bulb
- Olive leaf and olives
- Omega 6 fatty acid
- OMF's Repository
- Opioid-induced hyperalgesia
- Opioids
- Opposing MEGA
- Oral microbiome
- Oral rehydration salts
- Organic anion transporting polypeptide 1B1
- Organophosphate
- Orientation in space problems
- Ornithine
- Osteoporosis
- Oxaloacetate
- Oxfordshire ME Group for Action
- Oxidative phosphorylation
- Oxygen
- Oxytocin
- Ozone
P
- P-value
- Pacing with a heart rate monitor
- Pain catastrophizing
- Paleo diet
- Pancreas
- Panic attack
- Panic disorder
- Pantothenic Acid
- Paolo Maccallini
- Paraguay
- Paresis
- Parkinson's disease
- Passiflora
- Pathogen
- Patient-Led Research Collaborative
- Patricia Zunszain
- Paul McCrone
- Paul van Meerendonk
- Penny Friedman
- Penny Whiting
- Peptidyl-prolyl cis-trans isomerase F, mitochondrial precursor
- Pericarditis
- Periodic limb movement disorder
- Peripheral nervous system
- Peroxisome
- Peroxisome proliferator activated receptor alpha
- Peroxynitrite
- Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
- Persistent infection hypothesis
- Personality change
- Personality traits and patient attitudes in ME/CFS
- Peru
- Peter Del Fante
- Peter Smith
- Peter Tarbleton
- Phenylalanine
- Philip Stark
- Philippa Whitford
- Phillipe Bottello
- Phosphorus
- Physiology
- Picornavirus
- Pierre Flor-Henry
- Planning problems
- Plasma
- Platelet
- Pleuritis
- Poland
- Poliomyelitis
- Polymyalgia rheumatica
- Polyphenol
- Polyunsaturated fatty acids
- Help:Portals
- Portugal
- Post-exertional exhaustion: immediate or delayed
- Post-infectious Fatigue Syndrome
- Pradip Joshi
- Prednisone
- PrescriptAssist
- Procaine
- Prolapsed mitral valve
- Proline-rich transmembrane protein 4
- Prostacyclin
- Prostaglandin
- Protein tyrosine phosphatase non-receptor type 22
- Proton pump inhibitor
- Psychoneuroimmunology
- Psychosomatic illness
- Psychotherapy for mental illness
- PubMed
- Purinergic P2X 4 receptor
- Purinergic P2X 5 receptor
- Purinergic P2X 7 receptor
- Pyrroloquinoline Quinone
R
- Randomized controlled trial
- Ranitidine
- Raoulic acid
- Rashmi Cabena
- Raymond Perrin
- Rebecca Patterson Collier
- Rebecca Walwyn
- Receptive language problems
- Receptor for advanced glycosylation end-product
- Recovery period is prolonged, usually taking 24 hours or longer
- Regulated upon activation, normally T-expressed, and presumably secreted
- ReMEmberCFS
- Resolvin
- Respiratory depression
- Rest Ice Compression Elevate therapy
- Retractions, corrections and expressions of concern in chronic fatigue syndrome research
- Rich Van Konynenburg
- Richard Edwards
- Richard Kwiatek
- Rivaroxaban
- RNA
- RNase enzyme deficiency disease
- Robert Fredericks
- Robert Phair
- Rod Liddle
- Roland Staud
- Romania
- Rosane Nisenbaum
- Rosemary Ffrench